Positron Corporation announced a co-marketing agreement with Biologics Modular. Biologics Modular designs and manufacturers modular facilities that serve as self-contained biorepositories, biomanufacturing suites and research suites. PosiRx provides its users the ability to create patient specific unit doses in an ISO Class 5 environment and aids in compliance with USP 797 regulations.

For those customers that need additional cleanroom capacity, such as pharmacies providing custom compounding of cancer treatment therapies, Biologics Modular has the most comprehensive and cost effective solution on the market. By decreasing start-up time and reducing operational costs, the combined solution allows new markets to be serviced sooner, and more profitably, than previously possible.